RxDoctor Payments Data

Kevin Ray, DPM

Foot & Ankle Surgery · Orangeburg, SCNPI 1194752253

Payments from drug & device makers

What this record shows

27 manufacturers reported payments, led by Paragon 28, Inc. at 24.4% of the total.

$6,507in general payments, 2019–2025

Across 79 payments — averaging $82.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$2K
  • Treace Medical Concepts, Inc.$2K
  • Organogenesis Inc.$1K
  • Triad Life Sciences Inc.$470
  • Kerecis Limited$294
  • Smith+Nephew$208
  • plus $1K from 21 others
$22,306in ownership & investment interests, 2019–2025

Across 5 payments — averaging $4461.20 each. An ownership or investment interest held by the physician or an immediate family member.

  • Curvebeam LLC$22K

What the payments were for

  • Travel & lodging$2,73142%
  • Food & beverage$3,77758%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,507 in reported general payments places this provider in the 65th percentile of 87 foot & ankle surgery providers in South Carolina.

See all foot & ankle surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$65,782
Medicare patients
250
Services billed
1,998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox22$559
Ammonium Lactate12$283
Ketoconazole12$132

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Orangeburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →